30 closest matches · ranked by relevance
Critical Limb Ischemia
Primary: To Determine Platelet Inhibition Before and After Switching for Two Weeks From Clopidogrel to Ticagrelor in Patients With CLI. — 173; 140; 71; 63 P2Y12 reaction units…
Critical Limb Ischemia
Primary: Asses the Prevalence of High On-treatment Platelet Reactivity in Critical Limb Ischemia Patients Treated With Aspirin and Clopidogrel. — 18; 17; 8; 57 Participants
Critical Limb Ischemia
Primary: Wound Size, Amputation or Survival — 12; 3 participants — p=0.258
Critical Limb Ischemia
Primary: Amputation-free Survival — 50.7 percentage of participants
Critical Lower Limb Ischemia
Primary: Late Lumen Loss (LLL) of the Target Lesion by Quantitative Vascular Angiography (QVA) — 0.605; 0.616 mm
Critical Limb Ischemia · Chronic Limb-Threatening Ischemia
Primary: Amputation-free Survival — 90.6 Percentage of participants
Chronic Limb Threatening Ischemia
Primary: EuroQoL-5D Visual Acuity Scale (VAS) Score — 47.55; 69.15; 65.35 score on a scale — p=0.005
Critical Limb Ischemia
Primary: Treatment-Emergent Adverse Events. — 3; 3; 3; 3 Participants
Peripheral Artery Disease · Critical Limb Ischemia
Primary: Percentage of Calcium Removal Out of Lumen Gain as Assessed by IVUS — 25.0; 0.0 percentage of lumen gain — p=0.0220
Critical Limb Ischemia
Primary: Amputation-free Survival — 67.2 percentage of participants
Critical Limb Ischemia
Primary: Number of Participants With Adverse Events as a Measure of Safety and Major Limb Amputation Free Survival Post BMMNC Administration — 14; 3; 2; 2 participants
Critical Limb Ischemia · Vascular Diseases · Peripheral Arterial Disease
Primary: Number of Participants With Adverse Events (AEs) Suspected to be Related to Injections of AMG0001 — 1; 1; 1; 1 Participants
Lower Extremity Acute Limb Ischemia · LE ALI
Primary: Target Limb Salvage Rate — 109 Participants
Critical Limb Ischemia
Primary: Reintervention, Above Ankle Amputation and Restenosis (RAS) — 7; 4 Participants
Critical Limb Ischemia
Primary: Number of Participants With Treatment-emergent Adverse Events Following Intramuscular Administration of 8 and 16 mg Engensis (VM202) or Placebo in Subjects With Critical…
Trauma Injury
Primary: Total Bone Blood Flow (TBBF)-Post Osteotomy — 4.9 mL/min/100g
Peripheral Arterial Disease
Primary: Effect of Intensive Lipid Modification Medication Therapy on Progression of Atherosclerosis and Restenosis of Femoral Arteries Measured Using High Resolution Magnetic…
Peripheral Artery Disease
Primary: Six-minute Walk Distance — -6.4; 34.5; -15.1 meters
Peripheral Artery Disease
Primary: Exercise Tolerance Assessed by Measuring Distance (m) Walked in 6-minutes — 388.75; 414.96; 404.29; 419.73 meters
PAD
Primary: Change of Ankle Brachial Index (ABI) at 6-month Post-procedure. — 0.24; 0.44 ratio
Peripheral Arterial Disease
Primary: Walking Endurance — -14; 35 Meters
Peripheral Artery Disease (PAD); Intermittent Claudication
Primary: Number of Participants With Adverse Events (AEs), Drug-related AEs, Serious Adverse Events (SAEs) and Deaths — 18; 17; 4; 4 Participants
Critical Limb Ischemia
Primary: Number of Participants With Primary Patency — 70; 38 Participants
Diabetes · Infection
Primary: Efficacy of Timentin Delivered by PILP Procedure (Treatment Group) Versus Intravenous Delivery (Control Group) at Reducing Microbiological Load in Subjects With…
Peripheral Arterial Disease
Primary: Number of Participants With First Occurrence of Target Vessel Occlusion, Surgical Revascularization, Endovascular Revascularization, Major Amputation of Target Limb…
Peripheral Arterial Disease
Primary: Primary Efficacy Endpoint: Freedom From MALE — 144 Participants
Peripheral Artery Disease
Primary: Safety Endpoint: Number of Participants With Freedom From Major Adverse Events — 110 Participants
Peripheral Arterial Disease
Primary: Incidence of Major Cardiovascular Events — 112; 47; 51; 17 participants — p=<0.001
Peripheral Arterial Occlusive Disease
Primary: Complete Healing of Ischemic Necroses and Ulcerations at 12 Weeks After the End of Study Drug Treatment — 49; 43; 27; 30 participants — p=0.2587
Cardiovascular Diseases · Coronary Disease · Coronary Artery Disease
Primary: Primary Composite Outcome: Death From Cardiovascular Causes, Myocardial Infarction, or Hospitalization for Unstable Angina, Heart Failure, or Resuscitated Cardiac Arrest…